Traditional Chinese Medicine for Acute Stroke Recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether two herbal medicines (Dengzhan Xixin and Dengzhan Shengmai) can help people recover better after a recent stroke. Researchers will track how these medicines work in your body over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You had an acute ischemic stroke (a blood clot blocking blood flow to the brain) diagnosed within the past 48 hours
- Your stroke severity score (NIHSS) is between 4 and 25 points
- You were able to function independently before your stroke (modified Rankin Scale score below 2)
- You have not used similar herbal supplements containing erigeron, ginseng, dwarf lilyturf, or schisandra in the past 2 weeks
- You do not have severe heart, liver, kidney, or breathing problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a traditional Chinese medicine treatment to standard care can improve recovery for people who have had a recent stroke and also have type 2 diabetes. The focus is on a specific Chinese medicine syndrome called 'toxin damaging brain collaterals.'
This trial tests whether a traditional Chinese medicine (Angong Niuhuang pill) made from different sources of a natural ingredient can help people who recently had a moderate stroke caused by a blood clot. It aims to see if the pill can improve recovery.
This trial tests a traditional Chinese medicine prescription called 'Th Tl Xb' to see if it can help repair blood vessel damage and improve fat metabolism in people who recently had a stroke. It is for people who had their first stroke about a month ago and also have heart artery disease.
This study uses traditional Chinese medicine (TCM) diagnostic tools to evaluate patients who had an ischemic stroke within the last 10 days. It aims to understand the acute and chronic phases of stroke to help guide future treatments.
This study tests a traditional Chinese herb formula called Qingre Huatan to see if it can stop stroke symptoms from getting worse in the first few days. It is for people who have had an ischemic stroke within the last 48 hours and are at high risk for early decline.
This trial tests a plant-based medicine called galantamine, given within 3 days of an ischemic stroke, to see if it helps recovery. It combines Western and Traditional Chinese Medicine approaches and aims to understand how the treatment works.
Hear when a new Traditional Chinese Medicine (TCM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.